USOR 23074 - Ph3 SGN-B6A vs docetaxel NSCLC

A randomized, phase 3, open-label study to evaluate SGN-B6A compared with docetaxel in adult subjects with previously treated non-small cell lung cancer (SGN-B6A-002)

Disease Types: Lung - Non-Small Cell Lung

Available at: Arlington Heights, Niles